DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

Synopsis of Current Program Funding Opportunities


FY20 Amyotrophic Lateral Sclerosis Research Program (ALSRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Therapeutic Development Award Program Announcement
Application Instructions
January 17, 2020
  • Maximum funding of $1.0 million for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application: April 15, 2020

Preproposal is required; application submission is by invitation only.

Application: July 23, 2020
Therapeutic Idea Award Program Announcement
Application Instructions
January 17, 2020
  • Maximum funding of $500,000 for direct costs (plus indirect costs).
  • Maximum funding of $600,000 for direct costs plus indirect costs if applying for the Therapeutic Relevant Biomarker Option.
  • Maximum period of performance is 2 years.
Pre-Application: April 15, 2020

Preproposal is required; application submission is by invitation only.

Application: July 23, 2020
Clinical Development Award Program Announcement
Application Instructions
January 17, 2020
  • Maximum funding of $300,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
Pre-Application: April 15, 2020

Preproposal is required; application submission is by invitation only.

Application: July 23, 2020


FY20 Autism Research Program (ARP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Trial Award Program Announcement
Application Instructions
February 27, 2020
  • The maximum period of performance is 4 years.
  • The maximum allowable funding for the entire period of performance is $2,000,000 in direct costs (plus indirect costs).

Early-Career Investigator Partnering PI Option:

  • The maximum period of performance is 4 years.
  • The maximum allowable funding for the entire period of performance is $2,300,000 for direct costs (plus indirect costs).
Pre-Application:
April 28, 2020

Invitation to Submit an Application:
June 2020

Application:
July 28, 2020
Idea Development Award Program Announcement
Application Instructions
February 27, 2020
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $550,000 in direct costs (plus indirect costs).
  • For multiple PIs, the combined funding for all PIs for the entire period of performance may not exceed $550,000 in direct costs (plus indirect costs).
Pre-Application:
April 28, 2020

Invitation to Submit an Application:
June 2020

Application:
July 28, 2020
Clinical Translational Research Award Program Announcement
Application Instructions
February 27, 2020
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $600,000 in direct costs (plus indirect costs).
Pre-Application:
April 28, 2020

Invitation to Submit an Application:
June 2020

Application:
July 28, 2020

FY20 Bone Marrow Failure Research Program (BMFRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Development Award Program Announcement
Application Instructions
March 9, 2020
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $325,000 in direct costs (plus indirect costs).
Pre-Application (Preproposal): May 11, 2020

Application: August 5, 2020


GWIRP

FY20 Gulf War Illness Research Program (GWIRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Award Program Announcement
Application Instructions
March 24, 2020 Maximum funding of $150,000 for direct costs (plus indirect costs).

Maximum funding of $170,000 for direct costs with the Biorepository Contribution Option (plus indirect costs).

Maximum period of performance is 2 years.

Pre-Application (Preproposal): May 29, 2020

Application: September 10, 2020
Research Advancement Award Program Announcement
Application Instructions
March 24, 2020 Maximum funding of $625,000 for direct costs (plus indirect costs).

Maximum funding of $645,000 for direct costs with the Biorepository Contribution Option (plus indirect costs).

Maximum period of performance is 3 years

Pre-Application (Preproposal): May 29, 2020

Application: September 10, 2020
Clinical Evaluation Award Program Announcement
Application Instructions
March 24, 2020 Maximum funding of $1,500,000 for direct costs (plus indirect costs).

Maximum funding of $1,520,000 for direct costs with the Biorepository Contribution Option (plus indirect costs).

Maximum funding of $1,700,000 for direct costs with the Clinical Consortium Collaboration Option (plus indirect costs).

Maximum period of performance is 3 years

Pre-Application (Preproposal): May 29, 2020

Application: September 10, 2020
Therapeutic/Biomarker Trial Award Program Announcement
Application Instructions
March 24, 2020 Maximum funding of $5,000,000 for direct costs (plus indirect costs).

Maximum funding of $5,020,000 for direct costs with the Biorepository Contribution Option (plus indirect costs).

Maximum funding of $5,500,000 for direct costs with the Clinical Consortium Collaboration Option (plus indirect costs).

Maximum period of performance is 4 years

Pre-Application (Preproposal): May 29, 2020

Application: September 10, 2020
Patient-Provider and Health Communications Award Program Announcement
Application Instructions
March 24, 2020 Maximum funding of $600,000 for direct costs (plus indirect costs).

Maximum period of performance is 3 years.

Pre-Application (Preproposal): May 29, 2020

Application: September 10, 2020
New Investigator Award Program Announcement
Application Instructions
March 24, 2020 Maximum funding of $500,000 for direct costs (plus indirect costs).

Maximum funding of $520,000 for direct costs with the Biorepository Contribution Option (plus indirect costs).

Maximum period of performance is 3 years.

Pre-Application (Preproposal): May 29, 2020

Application: September 10, 2020


FY20 Lung Cancer Research Program (LCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Career Development Award Program Announcement
Application Instructions
March 24, 2020
  • Maximum funding of $250,000 in direct costs (plus indirect costs).
  • Period of performance not to exceed 2 years.
Pre-Application (Letter of Intent):
July 15, 2020

Letter of Intent is required.

Application: July 29, 2020
Clinical Translational Research Partnership Award Program Announcement
Application Instructions
March 24, 2020
  • Maximum combined funding of $1,200,000 in direct costs (plus indirect costs).
  • Period of performance not to exceed 3 years.
Pre-Application (Letter of Intent):
July 15, 2020

Letter of Intent is required.

Application: July 29, 2020
Concept Award Program Announcement
Application Instructions
March 12, 2020
  • Maximum funding of $100,000 in direct costs (plus indirect costs).
  • Period of performance not to exceed 1 year.
Pre-Application (Letter of Intent): May 27, 2020

Letter of Intent is required.

Application: June 10, 2020
Idea Development Award Program Announcement
Application Instructions
March 12, 2020
  • Maximum funding of $350,000 in direct costs (plus indirect costs).
  • Period of performance not to exceed 2 years.
Pre-Application (Preproposal): May 6, 2020

Preproposal is required; application submission is by invitation only.

Application: July 29, 2020
Investigator Initiated Translational Research Award Program Announcement
Application Instructions
March 12, 2020
  • Maximum funding of $400,000 in direct costs (plus indirect costs).
  • Period of performance not to exceed 2 years.
Pre-Application (Preproposal): May 6, 2020

Preproposal is required; application submission is by invitation only.

Application: July 29, 2020


FY20 Military Burn Research Program (MBRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Translational Research Award Program Announcement
Application Instructions
March 16, 2020
  • Maximum funding of $1.5 million for total costs (direct costs plus indirect costs).
  • Maximum period of performance is 4 years.
Pre-Application (Preproposal):
May 15, 2020

Invitation to Submit an Application:
June 18, 2020

Application:
August 20, 2020

FY20 Neurofibromatosis Research Program (NFRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Trial Award Program Announcement
Application Instructions
March 31, 2020
  • The maximum period of performance is 4 years.
  • The maximum allowable funding for the entire period of performance is $800,000 in direct costs ($1,000,000 in direct costs if requesting the Qualified Collaborator Option).
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent):
June 25, 2020

Application:
July 9, 2020
Exploration - Hypothesis Development Award Program Announcement
Application Instructions
March 31, 2020
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $100,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent):
June 25, 2020

Application:
July 9, 2020
New Investigator Award Program Announcement
Application Instructions
March 31, 2020
  • The maximum period of performance is years.
  • The maximum allowable funding for the entire period of performance is $450,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent):
June 25, 2020

Application:
July 9, 2020
Early Investigator Research Award Program Announcement
Application Instructions
March 31, 2020
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $200,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent):
June 25, 2020

Confidential Letters of Recommendation:
July 14, 2020

Application:
July 9, 2020
Synergistic Idea Award PENDING RELEASE

DEADLINE TO BE DETERMINED
TBD PENDING RELEASE

DEADLINE TO BE DETERMINED
PENDING RELEASE

DEADLINE TO BE DETERMINED
Investigator-Initiated Research Award PENDING RELEASE

DEADLINE TO BE DETERMINED
TBD PENDING RELEASE

DEADLINE TO BE DETERMINED
PENDING RELEASE

DEADLINE TO BE DETERMINED

FY20 Orthotics and Prosthetics Outcomes Research Program (OPORP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Research Award (CRA) Program Announcement
Application Instructions
March 31, 2020 The FY20 CRA offers two funding levels: Funding Level 1:
  • Maximum funding of $350,000 for total costs (direct costs plus indirect costs).
  • Maximum period of performance is years.
Funding Level 2:
  • Maximum funding of $2,000,000 for total costs (direct costs plus indirect costs).
  • Maximum period of performance is years.
Pre-Application (Letter of Intent):
July 15, 2020

Application:
July 29, 2020
Clinical Trial Award (CTA) Program Announcement
Application Instructions
March 31, 2020 The FY20 CTA offers two funding levels: Funding Level 1:
  • Maximum funding of $350,000 for total costs (direct costs plus indirect costs).
  • Maximum period of performance is years.
Funding Level 2:
  • Maximum funding of $4,000,000 for total costs (direct costs plus indirect costs).
  • Maximum period of performance is years.
Pre-Application (Letter of Intent):
July 15, 2020

Application:
July 29, 2020

FY20 Ovarian Cancer Research Program (OCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Translational Research Award Program Announcement
Application Instructions
February 27, 2020
  • Maximum funding of $450,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application:
April 30, 2020

Application:
July 30, 2020
Investigator-Initiated Research Award Program Announcement
Application Instructions
February 27, 2020
  • Maximum funding of $600,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
Pre-Application:
April 30, 2020

Application:
July 30, 2020
Ovarian Cancer Academy Award - Early-Career Investigator Program Announcement
Application Instructions
February 27, 2020
  • Maximum funding of $725,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
Pre-Application:
April 30, 2020

Application:
July 30, 2020
Pilot Award Program Announcement
Application Instructions
February 27, 2020
  • Maximum funding of $250,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
Pre-Application:
April 30, 2020

Application:
July 30, 2020
Proteogenomics Research Award Program Announcement
Application Instructions
April 2, 2020
  • Maximum funding of $250,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
Pre-Application:
July 16, 2020

Application:
July 30, 2020


FY20 Peer Reviewed Cancer Research Program (PRCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Virtual Cancer Center Director Award Program Announcement
Application Instructions
March 23, 2020
  • Maximum funding for the entire period of performance is $1,250,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
Pre-Application (Letter of Intent):
July 30, 2020

Application: August 20, 2020
Career Development Award - Fellow Option Program Announcement
Application Instructions
March 23, 2020
  • Maximum funding for the entire period of performance is $400,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application (Letter of Intent):
July 30, 2020

Application: August 20, 2020
Career Development Award – Virtual Cancer Center Scholar Option Program Announcement
Application Instructions
March 23, 2020
  • Maximum funding for the entire period of performance is $800,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
Pre-Application (Letter of Intent):
July 30, 2020

Application: August 20, 2020
Idea Award Program Announcement
Application Instructions
March 23, 2020
  • Maximum funding for the entire period of performance is $500,000 for direct costs (plus indirect costs).
  • Maximum period of performance is up to 3 years.
Pre-Application (Preproposal):
May 14, 2020

Preproposal is required; Application submission is by invitation only.

Application:
August 27, 2020
Impact Award Program Announcement
Application Instructions
March 23, 2020
  • Maximum funding for the entire period of performance is $1,000,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application (Preproposal):
May 14, 2020

Preproposal is required; Application submission is by invitation only.

Application:
August 27, 2020
Behavioral Health Science Award Program Announcement
Application Instructions
March 23, 2020
  • Maximum funding for the entire period of performance is $1,000,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
Pre-Application (Letter of Intent):
July 30, 2020

Application: August 27, 2020
Translational Team Science Award Program Announcement
Application Instructions
March 23, 2020
  • Maximum funding for the entire period of performance is $1,500,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
Pre-Application (Letter of Intent):
July 30, 2020

Application: August 27, 2020

FY20 Peer Reviewed Medical Research Program (PRMRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Discovery Award Program Announcement
Application Instructions
Updated March 31, 2020 Maximum funding of $200,000 for direct costs (plus indirect costs).

Maximum period of performance is 2 years.

Pre-Application (Letter of Intent): May 7, 2020

Application: May 21, 2020
Focused Program Award Program Announcement
Application Instructions
Updated March 31, 2020 Maximum funding of $7.2 million for direct costs (plus indirect costs).

Maximum period of performance is 4 years.

Pre-Application (Preproposal): April 30, 2020

Application: August 13, 2020
Investigator-Initiated Research Award Program Announcement
Application Instructions
Updated March 31, 2020 Maximum funding of $1.6 million for direct costs (plus indirect costs); $2.0 million for direct costs (plus indirect costs) for applications including a Partnering PI Option.

Maximum period of performance is 4 years.

Pre-Application (Preproposal): May 1, 2020

Application: September 3, 2020
Technology/Therapeutic Development Award Program Announcement
Application Instructions
Updated March 31, 2020 Maximum funding of $4.0 million for direct costs (plus indirect costs).

Maximum period of performance is 4 years.

Pre-Application (Preproposal): May 1, 2020

Application: September 3, 2020




FY20 Peer Reviewed Orthopaedic Research Program (PRORP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Applied Research Award (ARA) Program Announcement
Application Instructions
March 16, 2020
  • Maximum funding of $725,000 for total costs (includes direct and indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application (Preproposal):
May 27, 2020

Application:
September 10, 2020
Clinical Trial Award (CTA) Program Announcement
Application Instructions
March 16, 2020 Funding Level 1:
  • Maximum funding of $2.25 million (M) for total costs (includes direct and indirect costs).
  • Maximum period of performance is 4 years.
Funding Level 2: (Translation of Early Findings – Soft Tissue Trauma Focus Area with Rehabilitation Option):
  • Maximum funding of $2.75 million (M) for total costs (includes direct and indirect costs).
  • Maximum period of performance is 4 years.
Pre-Application (Preproposal):
May 27, 2020

Application:
September 10, 2020
Clinical Translational Research Award (CTRA) Program Announcement
Application Instructions
March 16, 2020
  • Maximum funding of $1.5 million (M) for total costs (includes direct and indirect costs).
  • Maximum period of performance is 4 years.
Pre-Application (Preproposal):
May 27, 2020

Application:
September 10, 2020


FY20 Prostate Cancer Research Program (PCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Early Investigator Research Award Program Announcement
Application Instructions
March 18, 2020
  • Maximum of $300,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
Pre-application (Letter of Intent): June 4, 2020

Confidential Letters of Recommendation: June 23, 2020

Application: June 18, 2020
Physician Research Award Program Announcement
Application Instructions
March 18, 2020
  • Maximum funding of $750,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
Pre-application (Letter of Intent): June 4, 2020

Confidential Letters of Recommendation: June 23, 2020

Application: June 18, 2020

FY20 Spinal Cord Injury Research Program (SCIRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Trial Award Program Announcement
Application Instructions
March 19, 2020
  • Maximum funding of $3 million (M) for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
Pre-Application (Preproposal): May 21, 2020

Application:
August 25, 2020
Translational Research Award Program Announcement
Application Instructions
March 19, 2020
  • Maximum funding of $1.25M for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application (Preproposal): May 21, 2020

Application:
August 25, 2020
Investigator-Initiated Research Award Program Announcement
Application Instructions
March 19, 2020
  • Maximum funding of $500,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application (Preproposal): May 21, 2020

Application:
August 25, 2020


FY20 Tick-Borne Disease Research Program (TBDRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Career Development Award Program Announcement
Application Instructions
March 17, 2020
  • Maximum funding of $300K for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application (Preproposal): May 27, 2020

Preproposal is required; application submission is by invitation only.

Application: August 27, 2020
Idea Award Program Announcement
Application Instructions
March 17, 2020
  • Maximum funding of $600K for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application (Preproposal): May 27, 2020

Preproposal is required; application submission is by invitation only.

Application: August 27, 2020


FY20 Tuberous Sclerosis Complex Research Program (TSCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Exploration - Hypothesis Development Award Program Announcement
Application Instructions
April 1, 2020
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $150,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
Pre-Application (Letter of Intent): June 18, 2020

Application: July 9, 2020
Idea Development Award Program Announcement
Application Instructions
April 1, 2020
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $450,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
Pre-Application (Letter of Intent): June 18, 2020

Application: July 9, 2020
Clinical Translational Research Award Program Announcement
Application Instructions
April 1, 2020
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $600,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
Pre-Application (Letter of Intent): June 18, 2020

Application: July 9, 2020

Last updated Thursday, April 2, 2020